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Recognition of extended linear and cyclised polyketide mimics by 
a Type II acyl carrier protein.
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Polyketides are secondary metabolites which display both valuable pharmaceutical and agrochemical properties. 
Biosynthesis is performed by polyketide synthases (PKSs), and the acyl carrier protein (ACP), a small acidic protein, that 
transports the growing polyketide chain and is essential for activity. Here we report the synthesis of two aromatic probes 
and a linear octaketide mimic that have been tethered to actinorhodin ACP. These experiments were aimed at probing the 
ACP’s capacity to sequester a non-polar versus a phenolic aromatic ring (that more closely mimics a polyketide 
intermediate) as well as investigations with extended polyketide chain surrogates.  The binding of these mimics has been 
assessed using high-resolution solution NMR studies and high-resolution structure determination. These results reveal that 
surprisingly a PKS ACP is able to bind and sequester a bulky non-polar substrate containing an aromatic ring in a fatty acid 
type binding mode, but the introduction of even a small degree of polarity favours a markedly different association at a 
surface site that is distinct from that employed by fatty acid ACPs. 
Introduction 
Actinorhodin 1 (Figure 1) produced by the archetype type II 
polyketide synthase from Streptomyces coelicolor, is an 
aromatic polyketide antibiotic that has served as a paradigm 
for the genetic, mechanistic and structural elucidation of 
aromatic polyketide biosynthesis1-4. It is produced by a Type II 
polyketide synthase, derived from a cluster of genes (23 in 
total) coding for each of the biosynthetic, self-resistance and 
export proteins associated with the actinorhodin pathway. 
Both studies in vivo and in vitro have shown that proteins 
encoded by actI (KS/CLF and ACP) form a minimal PKS5 that 
catalyses the generation of the full length polyketide chain 1 
(Figure 1).  Successive reductive (actIII, KR), 
cyclisation/aromatisation (actVII, ARO/CYC) and further 
tailoring steps then complete the biosynthesis. Whereas these 
latter tailoring steps follow a simpler enzyme-substrate model, 
the initial chain elongation steps involve precisely seven 
iterative decarboxylative condensations of seven malonate 
units with an acetate unit primer to give the desired chain 
length. 
 
 
Figure 1. Proposed biosynthetic pathway to actinorhodin 1. The polyketone 2 is 
attached to holo-ACP during the elongation of the polyketide backbone to the full 
sixteen carbon chain-length. Both studies in vivo and in vitro showed the proteins 
encoded by actI (KS/CLF and ACP), the so-called minimal PKS catalyses the generation 
of the full-length polyketide chain. The minimal PKS also partially controlled the C7-C12 
ring closure to yield SEK4 as well as a mis-cyclised product formed from the C10-C15 
ring closure (SEK4b).6 Ketide units are depicted in the keto-forms although these are 
likely to be a mixture of keto-enol tautomers.  
Studies of Type II FAS ACPs with fully reduced7, 8 or partially 
reduced fatty acids9 have revealed deep sequestration of the 
intermediate by the ACP and concomitant structural changes 
in the protein that may assist in modulating protein-protein 
interactions. Conversely the rat FAS Type I ACP bearing a fully 
reduced fatty acid chain showed no interaction of the protein 
with the fatty acid side-chain by NMR as evidenced by no 
observable NOEs or chemical shift perturbations in 1H-15N 
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HSQC spectra10. This has provided a useful yardstick to define 
the opposite ends of these two extremes. Very little is actually 
known about the mechanism by which a linear polyketide is 
successfully stabilised and transferred from the KS/CLF to the 
next enzyme in the sequence, actIII KR. Primarily this is 
because the ACP-bound labile intermediates are not isolatable 
and we lack suitable stable chemical mimics to serve as probes 
for these critical elongation steps. The ideal side chains for the 
study on ACP-intermediate interactions would be the true 
polyketide intermediates but their intrinsically high reactivity 
however of the native or postulated intermediates makes 
them unsuitable for structural studies and synthetically 
intractable. We have previously probed the structural role of 
act PKS ACP in binding and protection of the nascent 
polyketide using solution state NMR and acylated ACPs derived 
from chemically synthesized coenzyme A (CoASH) 
derivatives11. To generate more stable mimics we utilised 
polyketide analogs that employ strategically removed carbonyl 
positions but retain essential features such as flexibility of the 
intermediate and chain polarity. A terminal enone moiety is 
incorporated to allow Michael addition of the free sulfhydryl 
group of CoASH to generate a stable thioether group. Transfer 
of the intermediate and the 4’-phosphopantetheine (4’-PP) 
portion of CoASH is then transferred to the target ACP using 
ACPS12. Using this strategy we were able to provide evidence 
that short di-ketide and tri-ketide mimics show a weak 
association with the act PKS ACP11 and associated 
conformational exchange within the protein. NMR studies with 
emodin, a putative mimic of actinorhodin, have also suggested 
association with the ACP.13 
 All previous studies of early pathway intermediate 
analogues have, however, focused on short linear polar or 
non-polar chains, which surprisingly are sequestered by a PKS 
ACP. They have not addressed whether the ACP plays any role 
in interacting with longer or monocyclic intermediates that 
more closely resemble the critical assembly junctures in Type II 
polyketide biosynthesis. Many questions remain unanswered. 
1) The ACP’s true role in stabilising longer polyketide chains is 
unknown. 2) The timing of the first ring cyclisation is 
speculated to occur on the KR14 and does the ACP bind the 
resulting reduced cyclised product? Finally (3) what is the 
nature of the interaction of the ACP with these intermediates 
and will the ‘right’ intermediate show full sequestration like a 
fatty acid or does the true picture lie somewhere between this 
and the completely unbound model observed in Type I FAS 
systems?15 
Here we report the synthesis and structural 
characterisation of two aromatic derivatives and a linear 
octaketide surrogate covalently bound to the S. coelicolor 
actinorhodin (act) PKS ACP. The first, 5-phenyl-3-oxo-pentyl 
holo-ACP contains an unmodified aromatic ring and a high 
resolution NMR structure shows it is buried within the 
hydrophobic core of the ACP.  Two polar intermediates were 
then prepared, 6-(3-Hydroxyphenyl)hexyl holo ACP (phenolic 
ACP) containing a polar phenol group, was designed to more 
closely resemble an early stage polyketide intermediate and 
provide a comparison with the binding observed in 5-phenyl-3-
oxo-pentyl holo-ACP.  Similarly 3,7-dioxo-octyl ACP would also 
provide a direct comparison with the tight binding and 
sequestration observed previously in the non-polar octyl 
ACP11. In both cases we observe that the introduction of these 
moderate degrees of polarity can promote a rearrangement to 
an alternate binding mode where the derivative is associated 
with the surface of the ACP rather than within it. 
 
Scheme 1. (A) Synthesis of 5-phenyl-3-oxo-pentyl ACP. (B) Generalised CoASH 
derivative.  
Results and Discussion 
Synthesis and three-dimensional structure of 5-phenyl-3-oxo-
pentyl ACP 7.  
We began by synthesising 5-phenyl-3-oxopent-1-ene 5 in two 
steps via reaction of vinylmagnesium bromide with 
dihydrocinnamaldehyde followed by oxidation of allylic alcohol 
4 (Scheme 1).  Conjugate addition of CoASH to 5 gave 6 which 
was transferred by ACPS onto uniformly 15N-labelled apo act 
ACP to yield 5-phenyl-3-oxopentyl holo-ACP 7. This ligand was 
designed to determine whether the ACP is capable of adjusting 
to accommodate a non-substituted aromatic ring albeit with 
reduced functionality compared to the postulated early 
actinorhodin intermediate (Figure 1).  
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Figure 2. Comparison of the 
1
H-
15
N HSQC spectra of holo and aromatic act ACPs and 
chemical shift perturbations. (A) the overlaid 
1
H-
15
N HSQC of holo (red) and aromatic 
(orange) act ACPs. (B) ΔδNH between holo and aromatic act ACPs shown in column 
format where the height is proportional to the difference in ppm 
Initially, a comparison of 1H-15N HSQC spectra of holo and 
5-phenyl-3-oxopentyl ACP 7 (Figure 2A) revealed several 
significant chemical shift perturbations (CSPs) involving helix 
two and helix three (Figure 2B) as observed previously with 
buried non-polar and polar linear chains11. This indicated that 
the aromatic moiety might be tightly associated with the ACP.  
A sample of uniformly 13C, 15N labelled 5-phenyl-3-oxopentyl 
ACP was prepared and the solution structure solved using 
triple resonance techniques combined with 13C- and 15N-edited 
NOESY spectra. The solution structure of 7 was calculated 
using a total of 2424 NOE restraints and 55 TALOS φ/ψ 
dihedral angle restraints (See Table S1 for structural quality 
and statistics).16, 17 Two-dimensional 13C, 15N filtered NOESY 
spectra that distinguish NOEs arising from 12C and 13C bound 
protons were also employed to identify and confirm specific 
ligand-ligand and protein-ligand interactions (Figure S1). These 
experiments yielded 21 ligand-ligand interactions and 22 
protein-ligand NOEs, which defined the fold of the 4’-PP 
derivative and interactions between the aromatic ring and 
buried hydrophobes with the ACP. 
The structure of 5-phenyl-3-oxopentyl ACP 7‡ revealed a 
characteristic four-helical bundle topology (Figure 3A). The 
hydrophobic core is formed by Leu10 and Leu14 (helix 2), 
Leu45 and Leu52 (helix 2) and Leu74, Ile78 and Leu82 (helix 4) 
and Phe35, Ile38, Tyr40 and Ile60 on the inter-helical loops.  
Due to the relatively low number of protein - 4’-PP NOEs, the 
4’-PP portion of the derivatised side-arm appears flexible in 
the final ensemble.  Conversely, the phenyl ring is buried to 
the same degree in each of the calculated models (Figure 3A) 
residing approximately parallel to the helical axis of helix three 
and equidistant to helix two and three across the ensemble. 
The angle with which the phenyl ring points into the cavity is 
however much less well defined and a distribution of 
conformers is observed. Although the phenyl ring is 
completely buried in the protein cavity, the remaining 
backbone of the 5-phenyl-3-oxo-pentyl derivative is largely 
unprotected and the 3-keto group is blocked at the entrance 
of the cavity and lies at the surface of the protein (Figure 3B). 
Figure 3. Structural ensembles and representative model for 5-phenyl-3-oxo-
pentyl ACP 7. (A) The ensemble of twenty structures rendered as a Cα trace. The 
4’-PP derivative is represented in stick form and is buried in the core of the 
protein. (B) Ribbon image of the 5-phenyl-3-oxopentyl ACP 7 showing insertion of 
the phenyl moiety into the hydrophobic core of the protein. C. Pairwise 
superimposed structures of holo (orange), octanoyl (cyan) and 5-phenyl-3-
oxopentyl 7 (black) act ACPs. The residues, Leu45, Val68 and Leu74 are shown as 
sticks.  
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 Acylation of act ACP with hydrophobic derivatives drives a 
conformational change of helix three11 that opens an internal 
cavity lined by residues Leu45, Met46, Thr48, Ala49, Ile60, 
Ala65, Val68 and Leu74. Likewise these residues form a cavity 
for docking the phenyl ring that also includes Val64, Leu77 and 
Ile78 due to the larger bulk of this aromatic group versus a 
linear hydrophobic chain. The methyl groups of Leu45, Val68 
and Leu74 all show NOEs to the phenyl hydrogens and form 
the base of a cavity that binds the phenyl ring via numerous 
hydrophobic interactions. Based on the twenty calculated 
models, all conformers of the side chain of Leu45 and Val68 
and 85% of the conformers of the side chain of Leu74 are 
locked in a single conformation.  
Comparison with octanoyl ACP revealed that both octanoyl 
and 5-phenyl-3-oxopentyl ACP 7 are in the open 
conformations necessary for docking large hydrophobic side 
chains with similarities in amino acid side-chain conformations. 
The open cavity induced by the phenyl ring was, however, the 
largest we have observed to date at 222 Å3 compared to 188 
Å3 in octanoyl act ACP. The backbone φ angle of the hinge 
residues Ile60 and Val68 provides an indirect readout of the 
conformational change induced in helix three and reflects the 
expansion of the cavity. The φ angle for Ile60 was measured at 
-94° ± 6, similar to those of hexanoyl and octanoyl act ACPs (-
94° ± 2 and -94° ± 3, respectively)11 whereas the φ angle for 
Val68 was shifted to -108° ± 8 compared to -82 ± 2° in butyryl 
ACP, -86 ± 2° in hexanoyl ACP and -92 ± 4° in octanoyl ACP. The 
change in this latter value in particular further opens the 
internal cavity and the extra displacement around the C-
terminal of helix three allows act ACP to open and bind the 
bulkier phenyl ring. 
Synthesis of 6-(3-hydroxyphenyl)-3-oxo-hexyl (phenolic) act 
ACP 16 and 3,7-dioxo-octyl ACP 20. Having demonstrated the 
internal cavity of act ACP is able to expand and absorb a single 
phenyl group, we next determined whether incorporation of a 
greater degree of polarity would be accommodated in the 
same way or drive an alternative binding mode. To achieve this 
the phenolic CoASH derivative 15 was synthesised to explore 
whether the introduction of a single hydroxyl group on the 
aromatic ring would reduce or enhance binding to the ACP. 
Secondly an extended linear chain in the form of a 3,7-dioxo-
octyl group was conjugated to CoASH to give 19. This extended 
our previous studies to longer intermediates and tested 
whether increased chain length enhanced ACP binding, 
potentially through the selective binding of the hydrophobic 
face of the polyketide.   
For the phenolic ACP 16, protection of commercially 
available 3-bromophenol as silyl ether 8 followed by a 
Sonogashira cross-coupling with 3-butyn-1-ol gave alcohol 9 in 
76% yield over the two steps (Scheme 2). Reduction of the 
alkyne to 10 followed by Swern oxidation gave aldehyde 11 
which on treatment with vinylmagnesium bromide gave allylic 
alcohol 12. Acid hydrolysis of the TBS ether gave 13, which was 
oxidised with MnO2 to give the desired enone 14 albeit in low 
yield. The reactivity of this enone towards Michael addition 
with thiols was first tested using propanethiol to avoid 
unnecessary consumption of expensive CoASH. This reaction 
proceeded cleanly within 1 h by NMR and could also be carried 
out in water without loss of reactivity or selectivity. These 
conditions were then used to tether the enone to CoASH to 
give 15 and then to the ACP to yield 16. 
  
Scheme 2. (A) Synthesis of phenol-derived enone 14 and derivatised ACP 16. (B) Route 
to 3,7-dioxo-oct-1-ene 18 and derivatised ACP 20.  
 
For the synthesis of 20 (Scheme 2), treatment of the δ-
hexalactone with vinylmagnesium bromide gave alcohol 17. 
Dess-Martin oxidation yielded enone 18 which subsequently 
reacted via a Michael addition with CoASH to yield 19 and then 
to the ACP to give 20. 
We utilised 1H-15N HSQC spectra to probe the interaction of 
both polar analogs with act ACP (Figure 4A, B). We observed 
CSPs relative to holo-ACP for both analogues although the 
magnitude of the changes was reduced compared to the CSPs 
observed with 5-phenyl-3-oxopentyl ACP. This indicated that 
that sequestration within the cavity of the ACP and 
concomitant conformational changes in the protein were 
reduced, suggestive of a transient, possibly surface interaction 
with the protein. In fact a second conformation was observed 
for 3,7-dioxo octyl ACP 20 (Figure 5A) with chemical shifts of 
the minor form suggestive of shallow binding similar to that 
observed in butyryl act ACP11. Based on these observations we 
calculated the three-dimensional structure of 3,7-dioxo octyl 
ACP by solution state NMR (Figure 5B, See supporting 
information Table S2). This structure corresponded to the 
major conformer (with the smallest CSPs)
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Figure 4. Chemical shift perturbations derived from 3,7-dioxooctyl ACP 20 and 6-(3-hydroxyphenyl)hexyl ACP 16. (A) Comparison of the 1H-15N HSQC spectra of holo (red) and 3,7-
dioxooctyl ACP 20 (blue) and (B) associated CSPs. Blue bars represent the CSPs of the major form observed whilst a green bar is also shown when two different conformers were 
observable (i.e. for R67 and V68). (C) Comparison of the 1H-15N HSQC spectra of holo (red) and 6-(3-hydroxyphenyl)hexyl holo ACP 16 (purple) collected at 600 MHz and (D) 
associated CSPs. 
as the minor conformations were not in sufficient 
concentrations for NOEs to be observed. For the major 
conformer we observed numerous NOEs within the 4’-PP side-
arm (methylenes H6” and H9”, see supporting information 
Figure S2) which were not observed in holo-ACP but were also 
detected when the ACP was previously derivatised with 
shorter non-polar side-chains11. In addition 4’-PP – protein 
NOEs were observed from Leu 43 and Met 46. No NOEs could 
be observed to the 3,7-dioxo-octyl group. Nonetheless the 
NOEs that were observed were sufficient to define the 
topology of the 4’-PP sidearm which extends away from the 
ACP then folds back on itself to bring the thioether linkage 
close to helix two. This association is likely to be stronger in 
the two other sub-states that show greater protein CSPs and 
suggest the ACP is sensitised to the polar cargo and confers 
modest sequestration of the substrate, most likely by binding 
weakly along the charged groove between helices two and 
three (at the surface, rather than buried). Weak NOEs were 
observed previously from a short triketide analogue and 
emodic acid13, a surrogate for a more highly elaborated 
actinorhodin scaffold, to residues in helix two in act ACP. In 
addition binding has been detected in act ACP bearing longer 
polyketide mimics utilising carbonyl replacement. These 
studies combined molecular modeling and CSPs observed in 
helix three to suggest that residency of the polyketide mimic 
on the ACP increased in line with the length and degree of 
cyclisation of the polyketide18.  
 The similarity of the observed CSPs between the phenolic 
ACP 16 and the 3,7-dioxo-octyl ACP 20 led us to conclude that 
a similar binding mode would be observed for 16 and 
therefore we did not calculate a three-dimensional structure. 
The weak interaction with the phenolic derivative is however 
in stark contrast to the burial of the phenyl ring indicating that 
the introduction of the single hydroxyl group is sufficient to 
drive an exclusion of the phenolic group from within the 
binding cavity to a weaker interaction at the surface of the 
ACP. 
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The work of our group and others18, 19 now provides clear 
evidence that polyketide ACPs sequester their intermediates 
through a binding mode that is quite distinct from that 
employed in fatty acid synthesis (Figure 6). Why is fatty acid 
sequestration important in fatty acid biosynthesis? The binding 
cavity employed by type II FAS ACPs offers some protection 
from thioester hydrolysis which has been shown to increase in 
rate as the fatty acid exceeds ~ 14 carbons in length and 
outgrows the capacity of the ACP cavity although in vitro C18-
ACP preparations of these ACPs are stable for many days.20 
Burial of the fatty acid requires ‘chain-flipping’ of the fatty acid 
from the dynamic ACP to the more static fatty acid synthase 
enzymes (KS, KR, DH and ER) where neither association can be 
too stable as it would hinder the next flip21. By comparison, a 
model for the initial steps of polyketide biosynthesis involves 
the stabilisation of the polyketide by the catalytic KS/CLF 
during chain elongation to a precisely controlled chain 
length22. The active site is tube like and located at the interface 
of the two domains23. The elongated geometry of the site may 
assist in preventing unwanted spontaneous cyclisations and 
the amphipathic nature of this region may complement the 
nascent polyketide with suitable stabilising interactions, e.g. 
select ketide groups of the intermediate may be enolized to 
interact with two backbone carbonyls and a carboxylate side 
chain present in the amphipathic tunnel. In addition, a water 
molecule in the active tunnel may also play a role in stabilising 
the polyketide intermediate by donating a hydrogen bond to a 
ketone group. Once the mature polyketide has reached the 
correct length, a suitably strong interaction with the ACP might 
trigger dissociation with the ACP providing a suitably polar, but 
shallow cavity.  The partial sequestration of the polyketide 
may be sufficient to act as a solvent shield during transit to the 
KR. Within the complex milieu of the bacterial cell, the KR may 
of course be associated with the KS/CLF as a non-covalent 
complex requiring minimal translocation24. Our results taken 
together with related studies18 suggest that the ACP offers a 
degree of protection but in the absence of the next (i.e. KR) 
synthase component, the formation of SEK4b occurs, via an 
off-pathway C10-C15 cyclisation. In the normal pathway, the 
correctly C7-C12 cyclised product is then reduced to alcohol 2 
by the KR and blockage of biosynthesis at this point leads to 
the formation of mutactin.25 
 
Conclusions. It appears therefore that a polyketide ACP 
protects a more polar intermediate through an association at 
the surface of the protein between the cleft formed by helix 
two and three rather than deep burial of the non-polar chains 
observed in fatty acid synthesis. The association is strong 
enough to induce multiple conformers in the ACP when the 
polyketide chain is of sufficient length and contains polar 
atoms. These polar intermediates do not however induce the 
large cavity opening we observed when act ACP was 
derivatised with non-cognate fatty acids and the role, if any, of 
this potential internal hydrophobic pocket remains elusive. The 
observed association of the 4’-PP chain with the ACP would 
still therefore require a degree of chain flipping involving 
dissociation from the ACP surface prior to insertion into the 
active site of the next synthase partner in the biosynthetic 
sequence. This may be more easily or rapidly achieved in the 
Figure 5. Conformational sampling induced in the 3,7-dioxo-octyl ACP structures. (A) 
Expansion of the 1H-15N HSQC spectra plotted at lower contour levels than figure 4 
comparing 3,7-dioxo octyl ACP (orange), butyryl ACP (blue) and holo ACP (black). A 
second conformer observed in 3,7-dioxooctylACP indicates sampling of a partially 
opened structure approaching that of butyryl ACP (B) Ensemble of twenty structures 
of 3,7-dioxo-octyl ACP. (C) A single conformer of 3,7-dioxo-octyl ACP showing how 
intra-molecular 4’-PP interactions fold the polar intermediate back along helix two. 
Figure 6. Schematic representation of ACP (four helices as cylinders) and attached 
intermediate (black). (A) a type I FAS ACP ACP that does not sequester a fatty acid 
chain (B) type 2 (and most likely type 1) polyketide ACPs show partial sequestration of 
intermediate mimics and (C) Full sequestration of saturated fatty acid chains by type 2 
ACPs. 
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case of a surface associated polyketide intermediate versus a 
strongly bound fatty acid within a FAS ACP.  
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